15 February 2021 Priya Vaidya 2816 Case Updates Neurim Pharmaceuticals v Generics UK Limited [2020] EWHC 3270 (Pat) by Priya Vaidya The case: A patent case relating to prolonged release pharmaceutical formulations in which the active ingredient melatonin is intended to improve the restorative quality of sleep in a patient suffering from primary insomnia characterised by non-restorative sleep. The case called for experts in sleep medicine. To continue reading you must be an EWI member, become a member and access exclusive content. Already a member? Login Share Print Tags Bias06. Rules and Regulations11. Report Writing Related articles X and Y (Care Proceedings: Publication of Judgment: Criticism of Expert Witness), Re Expert Witnesses at a Turning Point Podcast Episode 28: Reflections on the EWI Conference 2026 A Day in the Life of a Dangerous Dog Legislation Expert Witness X and Y (Care Proceedings: Fact Finding: Death of a Child: Expert Evidence), Re [2025] EWFC 132 Switch article R (IJ (Kosovo)) v Secretary of State for the Home Department [2020] EWHC 3487 (Admin) Previous Article B v A [2020] EWHC 3138 (Fam) Next Article Comments are only visible to subscribers.